Michael Aaron Kelly Hookipa Pharma Inc. (HOOK) insider trading activity

Michael Aaron Kelly is Director of HOOKIPA Pharma Inc.. Currently has a direct ownership of 5,754 shares of HOOK, which is worth approximately $5,005. The most recent transaction as insider was on Oct 21, 2020, when has been sold 5,754 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.75K

0% 3M change

0% 12M change

Total Value Held $5,005

Michael Aaron Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 21 2020	BUY Grant, award, or other acquisition	-	5,754 Added 50.0%	5,754 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

NEO

NEOGENOMICS INC Healthcare

Director

BOOM

DMC Global Inc. Energy

Director

APRE

Aprea Therapeutics, Inc. Healthcare

Director

PRME

Prime Medicine, Inc.

Director

MAK